Last reviewed · How we verify
CALCIUM CITRATE
Calcium citrate is a marketed supplement primarily indicated for preconception nutritional support, competing in a crowded market of calcium-based products. Its key strength lies in its mechanism of providing essential calcium ions for bone health and density, supported by a key composition patent expiring in 2028. The primary risk is the presence of multiple same-class competitors, including off-patent calcium chloride and patent-protected calcium gluconate, which may limit market share and revenue growth.
At a glance
| Generic name | CALCIUM CITRATE |
|---|---|
| Drug class | calcium citrate |
| Modality | Small molecule |
| Therapeutic area | Hematology |
| Phase | FDA-approved |
Approved indications
- Preconception Nutritional Support
- Pregnancy Nutritional Support
- Postnatal Nutritional Support
Boxed warnings
- WARNING Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
Common side effects
- Allergic sensitization
Key clinical trials
- Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis (PHASE1)
- Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma (PHASE1)
- RELISTOR's Effects on Opioid-Induced Constipation
- Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia (PHASE2)
- Sodium Bicarbonate as an Alternative to Potassium Citrate for Kidney Stones (PHASE1,PHASE2)
- Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma (PHASE3)
- Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study) (PHASE1)
- Vitamin D Homeostasis in Sarcoidosis (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CALCIUM CITRATE CI brief — competitive landscape report
- CALCIUM CITRATE updates RSS · CI watch RSS